EN DE

Lion Corporation (LIOPY) Fair Value & Analysis

Consumer Defensive · US · Market cap $2.3B

LC Lion Corporation logo Lion Corporation LIOPY · US
Price$16.40
Fair Value$23.26
Upside+41.8%
Quality62/100
Watch Lion Corporation for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 6.5% net margin
Low debt · generates free cash flow
2.23% dividend yield
Ranks above peers (8/11)
Narrow moat 43/100
Evidence: Medium Range $16.96 – $29.96 Share as image

Fair value as of: Jul 17, 2026

From 22 valuation models · updated 24 days ago

A solid business, screening 42% undervalued on our models.

What matters now

  • The price is below even our cautious bear case ($16.96). The market is more pessimistic than our downside scenario.
  • Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$42.85 $15.51 Fair Value $23.26 Apr 2021 Jul 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range $15.51 – $42.85 · fair‑value band $16.96 – $29.96 · the $16.40 price screens below the $23.26 fair value. Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Lion Corporation (LIOPY) currently trades at $16.40, while our model-based Fair Value estimate is $23.26, implying the stock looks roughly 41.8% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Lion Corporation generated revenue of $427B at a net margin of 6.5%. Revenue grew 5.3% year over year. It earns a return on equity of 9.6%. The balance sheet holds a net cash position of $59.9B. Fundamentals as of Jul 17, 2026

Our scenario range runs from $16.96 (bear case) to $29.96 (bull case); at $16.40, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high and 3% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at 42%, LIOPY screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $14.67 $18.21 $23.39 80
Rev-Margin DCF $15.47 $21.35 $27.99 74
ROIC Compounder $13.51 $15.14 $16.95 72
All 22 models by family
DCF Models
FCF DCF $14.34 $18.05 $23.82 38
Owner Earnings $18.05 $23.08 $30.92 31
5Y Revenue Exit $15.47 $21.20 $28.78 39
5Y EBITDA Exit $20.63 $30.11 $41.49 41
5Y P/E Exit $18.84 $27.02 $35.79 38
10Y Revenue Exit $14.58 $19.47 $25.25 36
10Y EBITDA Exit $18.05 $25.27 $33.81 37
10Y P/E Exit $16.96 $23.26 $29.97 35
Earnings-Based
Graham-Dodd $8.82 $16.86 $21.02 54
EPV $13.51 $15.02 $16.32 59
Multiples
P/E Multiple $20.42 $27.23 $34.03 63
P/S Multiple $16.53 $22.04 $27.55 58
P/B Multiple $16.53 $22.04 $27.55 55
EV/EBIT $22.38 $28.53 $34.67 53
EV/EBITDA $27.72 $35.65 $43.57 54
EV/Revenue $17.11 $22.74 $28.38 43
Asset-Based
NCAV (Graham) $7.24 $9.70 $14.47 50
Growth DCF
Growth DCF $14.67 $18.21 $23.39 80
Rev-Margin DCF $15.47 $21.35 $27.99 74
Economic Profit
Residual Income $12.18 $13.21 $16.51 61
ROIC Compounder $13.51 $15.14 $16.95 72
Growth Earnings
Growth-Adj P/E $14.63 $20.91 $27.18 68

Widest divergence: DCF Models ($23.08) versus Asset-Based ($9.70). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $427B
Revenue growth (YoY) +5.3%
Net margin 6.5%
Return on equity 9.6%
Free cash flow $23.7B FY2025
P/E ratio 22.2
More key figures
Operating margin 6.3%
EPS (TTM) $0.7400
Dividend yield 2.2%
EPS growth (YoY) +4.5%
Net cash $59.9B FY2025

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100

Of which business quality 63 · Market factors (momentum, volatility) 55

Profitability 50
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 44
Earnings quality: real cash, not paper profit
Fin. Strength 78
Balance sheet, leverage, solvency risk
Investment 77
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 41
Price trend over the last 3–12 months (market factor)
52W Momentum 26
Distance to the 52-week high (market factor)
Net Issuance 88
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through Consumer Goods, Industrial Products, and Overseas segments.

Full company description

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through Consumer Goods, Industrial Products, and Overseas segments. The company provides oral healthcare products, including toothpastes, toothbrushes and cleaning tools, dental rinses and mouthwashes, periodontitis ointments, and denture products; beauty care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, hygiene care, body washes, acne care, antiperspirants and deodorants, men's care, and foot and heel care products, as well as oral health habit support program. It offers antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, antidiarrheal, gastrointestinal, acne, and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care and detergents products; household cleaners; and kitchen cleanup products. Further, it also provides pet healthcare and living care; novelty and special order products. Lion Corporation was founded in 1891 and is headquartered in Taito, Japan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Lion Corporation reported revenue of $443B in FY2025 versus $366B in FY2021, a compound +4.8%/yr. Reported net income was $28.9B in FY2025, compounding +5.0%/yr from FY2021.

Growth Quality 63/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$443B
Latest YoY
+7.2%
Avg. growth/yr (3Y)
+4.3%
Avg. growth/yr (5Y)
+4.5%
Avg. growth/yr (21Y)
+1.7%
Revenue +4.8%/yr
FY21 $366B
FY22 $390B
FY23 $403B
FY24 $413B
FY25 $443B
Net income +5.0%/yr
FY21 $23.8B
FY22 $21.9B
FY23 $14.6B
FY24 $21.2B
FY25 $28.9B

Watch LIOPY: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lion Corporation Fair Value". https://www.fairvalue-calculator.com/stock/LIOPY

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 62 · Above median
Fair Value upside +42% · Top 25%
Return on equity (TTM) 10% · Above median
Return on assets 4% · Above median
Net margin (TTM) 7% · Above median
Operating margin (TTM) 6% · Below median
Revenue growth 5% · Above median
Dividend yield (TTM) 2.2% · Below median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 22.2× · Pricier than median
P/FCF 0.1× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 89 · sector 28
FUTURE 27 · sector 4
PAST 38 · sector 26
HEALTH 100 · sector 98
DIVIDEND 45 · sector 50

Insider activity: 35/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare Lion Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Lion Corporation (LIOPY) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of $23.26 versus a price of $16.40, about +42% (undervalued).
What is the fair value of LIOPY?
Our model-based fair value for Lion Corporation is $23.26 (as of Jul 17, 2026), built from audited fundamentals. The current price is $16.40.
What is the quality score of LIOPY?
Lion Corporation has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Lion Corporation (LIOPY)?
Lion Corporation reported trailing-twelve-month revenue of about $427B (latest available figure, as of Jul 17, 2026).
What is the net profit margin of LIOPY?
The net profit margin of Lion Corporation is about 6.5%, meaning it keeps roughly 6.5% of revenue as net income. Based on the latest reported figures.
Does Lion Corporation pay a dividend?
Lion Corporation currently shows a dividend yield of about 2.23% relative to its recent price (as of Jul 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Lion Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.